How Referral Labs Track Commissions: A Guide for Diagnostic Networks in Nigeria

It's the last week of the month, and the lab manager at a mid-sized diagnostic network is doing what she does every month: reconstructing commission payouts for five partner collection centres from WhatsApp messages, a shared Excel sheet, and the accessioning register. One collection centre insists it sent 340 samples in June; the register shows 312. Another partner hasn't sent a running total at all and just wants "whatever's owed." By the time the numbers are reconciled, it's the second week of the following month — and one partner is now quietly asking whether a competing lab's payout terms are easier to follow.

None of this is a scandal. It's just an unmanaged process. Referral-partner commissions are a normal part of running a diagnostic network with collection centres, franchise units, or corporate accounts feeding samples to a central lab — the problem here isn't that commissions exist, it's that nobody can produce a clean, auditable record of what's owed to whom and why. That gap is where disputes start, and it's also where a lab can drift, without meaning to, from a transparent partner-fee structure into something closer to the kind of referral arrangement Nigerian medical ethics rules specifically exist to prevent.

This guide covers both halves of that problem: what legitimate referral-commission arrangements look like in diagnostics, where the professional-ethics line sits, and how to keep a clean, dispute-proof record of it all.

Quick Answer

Legitimate referral-commission arrangements in diagnostics are transparent, disclosed fees paid to partner facilities — collection centres, franchise/network lab units, corporate wellness accounts, or insurance/HMO panels — for the logistics of collecting, handling, and routing samples, not for influencing a clinician's referral decision. That distinction matters in Nigeria specifically: Section 65 of the Medical and Dental Council of Nigeria's (MDCN) Code of Medical Ethics prohibits fee-splitting arrangements tied to patient referrals, and a 2020 Premium Times investigation documented labs in Nigeria inflating test prices by 20-35% to fund kickbacks paid directly to referring doctors — the exact pattern professional bodies and this guide are careful to distinguish from. Labs that want to track referral relationships properly should build commission structures around partner facilities and business accounts, keep every commission rate disclosed and documented, and treat any arrangement involving payment to an individual licensed physician for referrals as a matter for their own legal and ethics counsel, not a default business practice. Software like ClinikEHR Diagnostics' referral network & commission tracking (Business Lab tier) exists to make the transparent version — referrer records, sample attribution, and auditable commission statements — fast and disputable-proof, not to automate the arrangement itself.

What Legitimate Referral-Partner Arrangements Look Like in Diagnostics

Reference labs everywhere run on referral networks — that's not unique to Nigeria and it isn't inherently a compliance problem. The diagnostics industry has a long-standing, ordinary business model built around a few recurring relationship types:

• Partner collection centres. A smaller facility — a clinic, a standalone collection point, or a franchise satellite location — draws and handles samples locally, then routes them to a central reference lab for processing. The collection centre earns a transparent service fee or a share of test revenue for the logistics work it actually performs: intake, phlebotomy, sample packaging, and cold-chain handling. This is functionally identical to a courier or agency fee — compensation for real, disclosed work.
• Franchise and network lab units. Multi-site lab groups (the kind covered in our medical laboratory franchise guide) often run internal referral arrangements between sister branches — a satellite branch refers a specialized test to the branch with the right analyzer, and revenue splits according to a pre-agreed formula. That's internal business accounting, not referral inducement, since the branches share ownership or franchise structure.
• Corporate and insurance/HMO accounts. Companies that route staff for occupational health panels, or HMOs that direct member testing to a preferred lab, typically negotiate a volume-based commercial rate — a standard B2B arrangement, documented in a contract, not a per-referral payment to an individual decision-maker.

What all three share is what makes them legitimate: the payment goes to a facility or business entity for disclosed services or contracted volume, at a rate that's written down and available to show any partner, auditor, or regulator who asks — not paid informally or in a way that avoids scrutiny.

The Ethical Line: Partner-Facility Fees vs. Paying Physicians to Refer

This is the part of referral tracking that a lab genuinely has to get right, and it's worth being direct about it rather than glossing over it.

Professional-ethics frameworks around the world draw a consistent distinction between two patterns that can look superficially similar but are treated very differently. In the United States, the Stark Law and the federal Anti-Kickback Statute — along with a 2014 OIG Special Fraud Alert specifically about laboratory payments to referring physicians — separate fair-market-value payment for actual services rendered (like a collection site handling fee, capped and consistent regardless of test volume) from payment structured to induce or reward referral volume, which is prohibited regardless of what it's called. A payment that scales with how many patients a physician sends, or that exceeds what the work performed is actually worth, is the pattern regulators flag first.

Nigeria has its own version of this principle. The MDCN's Code of Medical Ethics — the professional-conduct rulebook every registered doctor and dentist in Nigeria is bound by — addresses this directly: Section 65 identifies fee-splitting arrangements tied to referrals among the "unwholesome" transactions practitioners are prohibited from soliciting or entering into. That's not a theoretical concern. A 2020 Premium Times investigation (widely republished by outlets including Daily Trust and The ICIR) documented diagnostic labs in Nigeria paying referring doctors and hospitals kickbacks of roughly 10-20% of test costs, funded by inflating patient-facing prices by 20-35% — with some labs reportedly running loyalty-point schemes redeemable for cars, mortgages, or vacations tied directly to referral volume. That investigation is exactly the pattern this guide is written to help labs avoid building, even unintentionally, through an informal or badly-documented commission process.

The practical distinction for a lab building out referral tracking is this:

• Paying a partner facility — a collection centre, a franchise branch, a corporate account, an HMO panel — a disclosed, consistent fee for real logistics or contracted volume is normal diagnostics business, and the kind of arrangement this guide covers.
• Paying an individual licensed physician specifically to influence which lab they refer patients to sits in fundamentally different territory — ethically, and in many jurisdictions legally. If a lab is considering any arrangement that compensates an individual referring doctor tied to patient volume, that is a conversation for the lab's own legal and ethics counsel, not a default feature to configure in software. This guide does not recommend or walk through that arrangement, and nothing here should be read as a template for it.

Keeping that line explicit — in policy, in contracts, and in the software configuration itself — is what separates a defensible referral-partner program from the pattern regulators and professional bodies exist to catch.

Why Transparent Commission Statements Protect Everyone

Beyond the ethics question, there's a plainer business reason to formalize referral tracking: undocumented commission arrangements are a slow-motion trust problem, even when every party involved is acting in good faith.

• Disputes get resolved with a record, not a memory. When a collection centre and a lab disagree on sample counts — as in the opening scenario — the fix is a shared, timestamped log both sides can check, not a negotiation based on whoever's spreadsheet looks more confident.
• Partners can verify they're being paid the agreed rate. A statement showing the rate, sample count, and calculation removes the "trust us" element from a payout — which matters more as a network adds partner facilities.
• It creates the audit trail a regulator or assessor may ask for. A lab pursuing ISO 15189 accreditation (covered in our MLSCN and ISO 15189 readiness guide) should be able to show how referral relationships are structured and paid — a documented, exportable history answers that in minutes instead of a manual reconstruction.
• It's the difference that shows up if anyone ever asks. A lab with a written commission schedule, applied consistently and tied to facilities rather than individuals, is in a fundamentally different position than one relying on informal arrangements it would struggle to fully explain.

None of this requires exotic tooling — it requires treating referral relationships as a tracked business process, not an informal understanding between whoever answers the phone at month-end.

How ClinikEHR Diagnostics Handles Referral Network & Commission Tracking

ClinikEHR Diagnostics includes referral network and commission tracking as a live feature on the Business Lab tier ($127/month, ₦200,000/month — 25 staff, 3 labs plus 5 collection centres pre-bundled). In practice, that means the lab can maintain a record of its referring partners and generate commission statements tied to actual sample and test activity, rather than reconstructing figures manually every month from scattered logs.

That sits alongside two other Business Lab features worth knowing about for a network running referral partnerships at scale: advanced audit-log reporting (accreditation-ready exports), where the same underlying audit trail that supports MLSCN and ISO 15189 readiness documents referral and commission activity in a structured, exportable form; and advanced BI & executive analytics, useful for seeing which partners are actually driving volume as a reporting question, not just a payout one.

It's worth being clear about the tier structure, because it maps onto two different problems. The Starter Lab tier ($48/month, ₦75,000/month) includes a Referring-Doctor Portal — but that's specifically a result-delivery feature, giving referring clinicians a way to receive results digitally, with no commission-tracking or payout logic attached. That's the right tool for a lab that simply wants referring doctors to get results faster. Referral network and commission tracking — referrer relationships, sample attribution, and commission statements for partner facilities — is a separate, more advanced capability at Business Lab, aimed at networks actually running partner-facility or franchise commission structures.

Frequently Asked Questions

Is paying a referral commission to a partner facility or collection centre legal and ethical in Nigeria? Paying a disclosed, consistent service fee to a partner facility for real logistics work or contracted volume is standard diagnostics practice. The specific concern in Nigeria is payments to individual licensed physicians structured to influence referral decisions, which Section 65 of the MDCN Code of Medical Ethics prohibits as fee-splitting. Keep commission structures built around facilities and business accounts, and consult your own legal counsel before any arrangement involving an individual referring physician.

What's the difference between a collection centre commission and a physician kickback? A collection centre commission compensates a facility for disclosed logistics work at a documented rate applied consistently, regardless of which clinician orders a test. A physician kickback pays an individual doctor an amount tied to how many patients they personally refer, structured to influence their clinical decision. The 2020 Premium Times investigation into Nigerian diagnostic referral kickbacks documented exactly this pattern.

Does ClinikEHR Diagnostics' commission tracking feature pay or calculate commissions for individual referring doctors? The feature tracks referrer relationships and generates commission statements for referral partners a lab configures — built for the transparent partner-facility, franchise-network, and corporate-account use cases in this guide. It does not include or endorse configuration for paying individual physicians to influence referrals; labs considering that should seek their own legal and ethics guidance.

What's the difference between Starter Lab's Referring-Doctor Portal and Business Lab's referral network & commission tracking? Starter Lab's Referring-Doctor Portal is a result-delivery feature only — referring clinicians receive results digitally, with no commission logic. Business Lab's referral network & commission tracking is a separate, more advanced feature for tracking referrer relationships, sample attribution, and commission statements for partner facilities. A lab that only needs faster result delivery doesn't need to move beyond Starter Lab.

How does a franchise or multi-branch lab network typically split referral revenue between sister branches? Most multi-branch networks (see our medical laboratory franchise guide) use a pre-agreed revenue-share formula when one branch refers a specialized test to a sister branch — a documented internal accounting arrangement with a written rate, applied consistently, and a record either branch can check.

What documentation should a lab keep for referral-partner commission arrangements? At minimum: a written agreement or rate schedule with each partner, a record of the actual sample/test volume attributed to them, and a commission statement showing how the payout was calculated. Keeping this in a structured, exportable format — rather than reconstructed from messages each month — makes the arrangement quickly explainable if it's ever questioned.

Can commission tracking help with MLSCN or ISO 15189 accreditation readiness? Indirectly. Neither audit is specifically about commission structures, but both examine whether operational records are organized and traceable — our MLSCN and ISO 15189 readiness guide covers what those audits actually check. Clean, exportable referral records demonstrate the same documentation discipline an assessor looks for elsewhere.

Should a small, single-site lab worry about referral commission tracking at all? Not immediately. It becomes relevant once a lab has partner collection centres, franchise branches, or corporate/HMO accounts generating volume worth tracking — more a Professional Lab-to-Business Lab-stage concern than a day-one one. See our guide to setting up a medical laboratory in Nigeria for what matters at the founding stage.

Conclusion

Referral commissions are a normal, unavoidable part of running a diagnostic network with partner collection centres, franchise branches, or corporate accounts feeding it volume — the question isn't whether to track them, it's whether the tracking is transparent enough to survive a dispute, an audit, or a question from a regulator. Nigerian diagnostic labs have a specific reason to take that seriously: the MDCN's own Code of Medical Ethics draws a bright line against fee-splitting tied to referrals, and the pattern that line exists to prevent has been documented in Nigeria, not just hypothesized.

Key takeaways:

• Legitimate referral commissions go to partner facilities — collection centres, franchise branches, corporate/HMO accounts — for disclosed logistics work or contracted volume, not to individuals for influencing referrals.
• Section 65 of the MDCN Code of Medical Ethics prohibits fee-splitting arrangements tied to patient referrals; a 2020 Premium Times investigation documented the real-world version of that problem in Nigerian diagnostics.
• Any arrangement involving payment to an individual licensed physician for referrals belongs in front of a lab's own legal and ethics counsel, not treated as a default business practice.
• Transparent, documented commission statements protect both the lab and its partners from month-end disputes and give auditors or accreditation assessors a record instead of a reconstruction.
• ClinikEHR Diagnostics' referral network & commission tracking (Business Lab tier) is built for the transparent partner-facility and franchise-network version of this — separate from Starter Lab's simpler Referring-Doctor result-delivery portal.

Explore ClinikEHR Diagnostics to see referral network and commission tracking in detail.

Not sure where your lab stands? Talk to a consultant for free, personalized guidance.

Related Resources:

• Medical Laboratory Franchise Opportunities in Nigeria
• What Is a LIMS? Diagnostic Lab Software Explained
• MLSCN and ISO 15189 Readiness: How LIMS Software Helps You Pass Audits
• Best Guide to Setting Up a Medical Laboratory in Nigeria
• Top 5 Laboratory Management Software in Nigeria